No Results? No Problem! Why We Are Publishing Methods of a Landmark Study With Results Still Pending

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in both men and women in the United States, and screening for CRC is a national health-care priority. In this issue, investigators from the CONFIRM study group report on the aims and study design of a large, multicenter, randomized prospective study of whether screening colonoscopy is superior to an annual fecal immunochemical test (FIT). CONFRIM hopes to enroll 50,000 individuals, aged 50-75 years, from 46 Veterans Affairs Medical Centers and monitor them for 10 years. This article is unique in that no results are presented as the study is not yet complete. We have taken this unusual step as we believe the topic of CRC screening is critically important for our readers and that the results of this massive study have the potential to change clinical practice throughout all fields of medicine.